GlassScriptPhysician profile
Amanda J Victory
NPI 1336359777
$2,990.08
in general payments reported to CMS, 2019-2025
22 companies · $26.58 in 2025
The $26.58 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $760 · 2020: $540 · 2021: $665 · 2022: $514 · 2023: $282 · 2024: $202 · 2025: $26.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $479.08 | 2019-2022 | |
| Therapeuticsmd, INC. | $336.71 | 2019-2022 | |
| Pfizer INC. | $306.13 | 2019-2023 | |
| Coopersurgical, INC. | $303.33 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $219.90 | 2021-2024 | |
| Agile Therapeutics, INC. | $197.85 | 2021-2024 | Twirla |
| Allergan, INC. | $161.98 | 2019-2020 | |
| Astellas Pharma US INC | $161.15 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $154.72 | 2019-2023 | |
| Exeltis, USA INC. | $136.80 | 2020-2022 | |
| Lupin INC. | $123.63 | 2019-2020 | |
| Amgen INC. | $70.85 | 2019-2023 | Prolia, Evenity |
| Daiichi Sankyo INC. | $62.15 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $56.72 | 2019-2020 | |
| Exact Sciences Corporation | $53.23 | 2024 | Cologuard Collection Kit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $51.58 | 2021 | |
| Hologic Sales and Service, LLC | $34.37 | 2019-2020 | |
| Glaxosmithkline, LLC. | $18.48 | 2021 | |
| Millicent US INC | $18.43 | 2019 | |
| Medicem INC. | $16.20 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.34 | 2020 | |
| Duchesnay USA Incorporated | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Victory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.